Grace Hallenbeck, DNP-FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 7237 Us-7, Pownal, VT 05261 Phone: 802-681-2780 |
News Archive
Owen Barder, a visiting fellow at the Center for Global Development, examines the relationship among aid donors, GAVI and pharmaceutical companies in a post on the center's "Global Health Policy" blog.
A new study published in the American College of Rheumatology (ACR) journal, Arthritis Care & Research, reveals that women with rheumatoid arthritis (RA) who were on methotrexate (MTX), a drug commonly used to reduce inflammation caused by RA, had lower rates of induced abortions compared to women with RA who were not exposed to the medication.
With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels.
Dr. Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type II dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
› Verified 9 days ago